RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Virus e VLP (virus like particles) di origine vegetale come vaccini per la malattia di Alzheimer (AD)
• 2 - Caratterizzazione strutturale e funzionale di peptidi sintetici per lo sviluppo di strategie antivirali
• 3 - Infezioni virali persistenti, latenti e croniche da virus a DNA e ad RNA: studio dei meccanismi di regolazione genica e della risposta immune.
• 4 - STRATEGIE INNOVATIVE PER LO STUDIO PRE-CLINICO DELLA EFFICACIA DI FARMACI E ANTICORPI NEUTRALIZZANTI UMANI CONTRO IL VIRUS DELL'EPATITE C (HCV).
• 5 - Genomica funzionale di Bovine herpesvirus type 4 (BoHV-4) sull'infezione/transduzione del sistema nervoso centrale del topo in vitro ed in vivo
• 6 - Infezioni respiratorie: epidemiologia molecolare, cross-protection e impatto delle strategie preventive
• 7 - Approcci vaccinali innovativi per il controllo delle infezioni erpetiche e papillomatose sessualmente trasmesse
• 8 - Risposte innate ed adattative contro le infezioni erpetiche e papillomatose sessualmente trasmesse: nuovi approcci preventivi
• 9 - Apoptosi ed Infezioni virali.
• 10 - Nuove strategie vaccinali contro la tubercolosi

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • MEDICINA INTERNA
• Area scientifico disciplinare: Scienze agrarie e veterinarie
  • PATOLOGIA VEGETALE

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

Classificazione geografica

• Regione: Basilicata

Bibliografia

Arazi, T., Huang, P.L., Huang, P., Zhang, L., Shiboleth, Y.M., Gal-On, A., and Lee-Huang, S. 2002. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII. Biochem Biophys Res Commun 292: 441-448.

Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H et al. 2000. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916-9.

Brennan, F.R., Gilleland, L.B., Staczek, J., Bendig, M.M., Hamilton, W.O., and Gilleland Jr, H.E. 1999. A chimaeric plant virus vaccine protects mice against a bacterial infection. Microbiology 145:2061-2067.

DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. 2001. Peripheral anti-A-beta antibody alters CNS and plasma A-beta clearance and decreases brain A-beta burden in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 98:8850-5.

El Attar, A.K., Shamloul, A.M., Shalaby, A.A., Riad, B.Y., Saad, A., Mazyad, H.M., and Keith, J.M. 2004. Expression of chimeric HCV peptide in transgenic tobacco plants infected with recombinant alfalfa mosaic virus for development of a plant-derived vaccine against HCV. African J Biotechn 3:588-594.

Fernàndez-Fernàndez, M.R., Martinez-Torrequadra, J.L., Casal, J.I., and Garcia, J.A. 1998. Development of an antigen presentation system based on plum pox potyvirus. FEBS Lett 427:229-235.

Gelinas DS, DaSilva K, Fenili D, St George-Hyslop P, McLaurin J. 2004. Immunotherapy for Alzheimer’s disease. Proc Natl Acad Sci USA 101:14657-62.

Haass C, Selkoe DJ. 1993. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta peptide. Cell 75:1039-42.

Joelson, T., Akerblom, L., Oxelfelt, P., Strandberg, B., Tomenius, K., and Morris, T.J.1997. Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J Gen Virol 78:1213-1217.

Johnson, J., Lin, T., and Lomonossoff, G. 1997. Presentation of heterologous peptides on plant viruses: genetics, structure and function. Ann Rev Phytopathol 35:67-86.

Koo, M., Bendahmane, M., Lettieri, G.A., Paoletti, A.D., Lane, T.E., Fitchen, J.H., Buchmeier, M.J., and Beachy R.N.1999. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci USA 96:7774-7779.

Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Desai R et al. 2000. Nasal A-beta treatment induces anti-A-beta antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann NY Acad Sci 920:328-31.

Leverone JF, Spooner ET, Lehman HK, Clements JD, Lemere CA. 2003. A-beta1-15 is less immunogenic than A-beta1-40/42 for intranasal immunization of wild-type mice but may be effective for “boosting”. Vaccine 21:2197-206.

Lorenzo A, Yankner BA. 1994. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91:12243-7.

Marusic, C., Rizza, P., Lattanzi, L., Mancini, C., Spada, M., Belardelli, F., Benvenuto, E., and Capone, I. 2001. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol 75:8434-8439.

McLain, L., Durrani, Z., Wisniewski, L.A., Porta, C., Lomonossoff, G.P., and Dimmock, N.J. 1996. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14:799-810.

McLaurin J, Yang DS, Yip CM, Fraser PE. 2000. Review: modulating factors in amyloid-beta fibril formation. J Struct Biol 130:259-70.

Natilla, A., Piazzolla, G., Nuzzaci, M., Saldarelli, P., Tortorella, C., Intonaci, S., and Piazzolla, P. 2004. Cucumber mosaic virus as a carrier of a hepatitis C virus-derived epitope. Arch Virol 149:137-154.

Nemchinov, L.G., Liang, T.J., Rifaat, M.M., Mazyad, H.M., Hadidi, A., and Keith, J.M. 2000. Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch Virol 145:2557-2573.

Nicholas, B.L., Brennan, F.R., Martinez-Torrecuadrada, J.L., Casal, J.I., Hamilton, W.D., and Wakelin, D. 2002. Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses. Vaccine 20:2727-2734.

Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC et al. 2003. Sub-acute meningoencephalitis in a subset of patients with AD after A-beta42 immunization. Neurology 61:46-54.

Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M et al. 2002. Cerebral hemorrhage after passive anti-A-beta immunotherapy. Science 298:1379.

Piazzolla, P., Tamburro, A.M., and Renugopalakhrishnan V. 1991. Structural studies of cucumber mosaic virus: Fourier transform
infrared spectroscopic studies. In: Renugopalakrishnan V., Carey P.R., Smith I.C.P., Huang S.G., Storer A.C. (eds). Proteins. Escom
Science Publishers, Leiden, Netherlands, 133-137.

Piazzolla, P., Crescenzi, A., De Biase, M., and Tamburo, A.M. 1998. Circular dichroism studies of CMV-D and CMV-S: two strains of cucumber mosaic cucumovirus with a different biological behaviour. Arch Virol 143:2305-2312.

Piazzolla, G., Nuzzaci, M., Tortorella, C., Panella, E., Natilla, A., Boscia, D., De Stradis, A., Piazzolla, P., and Antonaci, S. 2005. Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine. J Clin Immun 25:142-152.

Porta, C., Spall, V.E., Loveland, J., Johnson, J.E., and Barker, P.J. 1994. Development of cowpea mosaic virus as a high-yielding
system for the presentation of foreign peptides. Virology 202: 949-955.

Renugopalakrishnan, V., Piazzolla, P., Lambda, O.P., and Tamburro, A.M. 1998. Structural studies of cucumber mosaic virus: Fourier transform infrared spectroscopic studies. Biochem Mol Biol Int 46:747-754.

Robinson SR, Bishop GM. 2002. A-beta as a bioflocculant:implications for the amyloid hypothesis of Alzheimer’s disease. Neurobiol Aging 23:1051-72.

Sadowski M, Wisniewski T. 2004. Vaccines for conformational disorders. Expert Rev Vaccines 3:279-90.

Sigurdsson EM, Knudsen E, Asuni A, Fitzer-Attas C, Sage D, Quartermain D et al. 2004. A modest immune response is sufficient to enhance cognition in an AD model immunized with A-beta derivatives. J Neurosci 24:6277-82.

Tacket Co, Mason HS. 1999. A review of oral vaccination with transgenic vegetables. Microbes Infect 1:777-83.

Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S. 2004. Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22:4385-9.

Thanavala Y, Mahoney M, Pal S, Scott A, Richter L, Natarajan N. 2005. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci USA 102:3378-82.

Turpen, T.H., Reini, S.J., Charoenvit, Y., Hoffman, S.L., Fallarme, V., and Grill, L.K. 1995. Malarial epitopes expressed on the
surface of recombinant tobacco mosaic virus. BioTech. 13: 53-57.

Van Regenmortel, M.H.V. 2000. Introduction to the species concept in virus taxonomy. Pages 3-16 in: Virus Taxonomy. M.H.V. van Regenmortel, C.M. Fauquet, D.H.L. Bishop, E.B. Carstens, M.K. Estes, S.L. Lemon, J. Maniloff, M.A. Mayo, D.J. McGeoch, C.R. Pringle, and R.B. Wickner, eds. Academic Press, San Diego, California, USA.

Yusibov, V., Hooper, D.C., Spitsin, S.V., Fleysh, N., Kean, R.B., Mikheeva, T., Deka, D., Karasev, A., Cox, S., Randall, J., and
Koprowski, H. 2002. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20:
3155-3164.

Zhang J, Wu X, Qin C, Qi J, Ma S, Zhang H et al. 2003. A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer’s disease. Neurobiol Dis 14:365-79.

Parole Chiave

VIRUS VETTORI; VIRUS VEGETALI CHIMERICI; PEPTIDI SINTETICI; VIRUS DEL MOSAICO DEL CETRIOLO; MALATTIA DI ALZHEIMER; VACCINO; BETA AMILOIDE; RISPOSTE IMMUNI; IMMUNIZZAZIONE ORALE